ASX:MVP Medical Developments International (MVP) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free MVP Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume169,499 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield0.77%Price TargetN/A Stock AnalysisStock Analysis Get Medical Developments International alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Medical Developments International Stock (ASX:MVP)Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.Read More Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. MVP Stock News HeadlinesApril 28, 2024 | omaha.comLincoln natives to be featured on HGTV's 'House Hunters International'April 27, 2024 | msn.comOpinion: Award Names Recognize The Moment, Not The MovementApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 26, 2024 | omaha.comA look at the Gaza war protests that have emerged on US college campusesApril 13, 2024 | msn.comBills Legend O.J. Simpson Dies at 76April 10, 2024 | sports.yahoo.com2024 Olympics Games in Paris - Yahoo SportsApril 7, 2024 | msn.comMeet the Globe’s all-time All-Scholastic hockey teamsApril 2, 2024 | finance.yahoo.comAre Investors Undervaluing Medical Developments International Limited (ASX:MVP) By 48%?April 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 28, 2024 | msn.comConcussion prevention and treatment protocols earn Dr. Mark Aubry induction into Ottawa Sports Hall of FameMarch 14, 2024 | msn.comDolphins add intriguing tight end talent who spent five years with Kansas City ChiefsMarch 14, 2024 | msn.comIntroducing the 17 girls basketball players nominated for the 2024 Dave Cowens AwardMarch 12, 2024 | finance.yahoo.comElectronic Medical Records Market to Surpass $46.96 Billion by 2028, Lead by Asia-Pacific Growth and AI TrendsMarch 7, 2024 | msn.comGoogle Gemini is 'the tip of the iceberg': AI bias can have 'devastating impact' on humanity, say expertsFebruary 24, 2024 | msn.comGovt looks to private sector in medical imports reduction effortsFebruary 23, 2024 | msn.comTexans Sign Defensive End Marcus HaynesFebruary 23, 2024 | msn.comIs Ex NFL Star Adrian Peterson Auctioning Off Accolades?February 21, 2024 | finance.yahoo.comIs Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?February 19, 2024 | msn.comMedical device sector expected to contribute RM20 billion to economy this yearFebruary 14, 2024 | finance.yahoo.comMedical Developments International Limited (MVP.XA)February 6, 2024 | msn.comFormer Texans Coach Tim Kelly Finds a New JobFebruary 4, 2024 | omaha.com'Friend of Ukraine': Warren Buffett's son provides $500 million in humanitarian aidJanuary 16, 2024 | bizjournals.comMVP Health Care appoints prominent executive to its boardJanuary 10, 2024 | morningstar.comMedical Developments International Ltd MVPJanuary 3, 2024 | finance.yahoo.comMedical Developments International (ASX:MVP) shareholders are up 36% this past week, but still in the red over the last three yearsSeptember 10, 2023 | finance.yahoo.comMVP.AX - Medical Developments International LimitedJuly 13, 2023 | msn.comAt 77, MVP has not stopped dreaming of a better future for allSee More Headlines Receive MVP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:MVP CUSIPN/A CIKN/A Webwww.medicaldev.com Phone61 3 9547 1888FaxN/AEmployees68Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,210,000.00 Net Margins-57.27% Pretax MarginN/A Return on Equity-23.42% Return on Assets-13.86% Debt Debt-to-Equity Ratio3.20 Current Ratio2.78 Quick Ratio2.54 Sales & Book Value Annual Sales$33.55 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow21.37 Book ValueA$0.88 per share Price / BookN/AMiscellaneous Outstanding Shares86,310,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.61 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Brent MacGregor (Age 60)Chief Executive Officer Comp: $758.49kMs. Anita JamesChief Financial OfficerMatthew CramerChief of Operations & Supply ChainMs. Tara EatonGeneral Counsel & Company SecretaryDr. Scott CourtneyChief Scientific OfficerWai Ng ChiHead of Regulatory AffairsWayne PearceHead of ProductionMr. Stefaan SchattemanHead of EuropeMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersGordon NaylorBought 56,000 shares on 9/7/2023Total: $49,560.00 ($0.89/share) MVP Stock Analysis - Frequently Asked Questions Is Medical Developments International a good dividend stock? Medical Developments International (ASX:MVP) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 0.77%. Read our dividend analysis for MVP. What other stocks do shareholders of Medical Developments International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Energy (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Wellness (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB). This page (ASX:MVP) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medical Developments International Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
